The influence of age and relative weight on the presentation of familial combined hyperlipidemia in childhood

Atherosclerosis

Volumn 121, Issue 1, 1996, Pages 85-91

  Shamir, Raanan ^a   Tershakovec, Andrew M ^a   Gallagher, Paul R ^a   Liacouras, Chris A ^a   Hayman, Laura L ^b   Cortner, Jean A ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA SCHOOL OF NURSING   (United States)

Author keywords

Age; Children; Cholesterol; Familial combined hyperlipidemia; Lipid disorders; Triglycerides; Weight

Indexed keywords

LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGE; ARTICLE; BODY WEIGHT; CHILD; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FAMILIAL HYPERLIPEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE;

EID: 0030050116     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05704-8     Document Type: Article

References (28)

1. Goldstein JL, Schrott HG, Hazzard WR, Beirman EL, Motulsky AG. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, familial combined hyperlipidemia. J Clin Invest 1973;52:1544-1568.
2. Goldstein JL, Hazzard WR, Schrott HG, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest 1973;52:1533-1543.
3. Grundy SM, Chait A, Brunzel JD. Familial combined hyperlipidemia workshop. Arteriosclerosis 1987;7:203-207.
4. Klag MJ, Ford DE, Mead LA, He J, Whelton PK, Liang KY, Levine DM. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 1993;328:313-318.
5. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. J Am Med Assoc 1990;264:3018-3024.
6. Castelli WP. Epidemiology of triglycerides: a review from Framingham. Am J Cardiol 1992, 70:3H-9H.
7. Assman G. Schulte H. Role of triglycerides in coronary artery disease: lessons from the prospective cardiovascular Munster Study. Am J Cardiol 1992;70:10H-13H.
8. Kwiterovich PO. Genetic and molecular biology of familial combined hyperlipidemia. Curr Opin Lipidol 1993;4:133-143.
9. Cortner JA, Coates PM, Liacouras CA, Jarvik GJ. Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management. J Pediatr 1993;123:177-184.
10. Iverius PH, Brunzell JD. Obesity and common genetic metabolic disorders. Ann Int Med 1985;103:1050-1051.
11. Sane T, Nikkila EA. Very low density lipoprotein triglyceride metabolism in relatives of hypertriglyceridemic probands. Evidence for genetic control of triglyceride removal. Arteriosclerosis 1988;8:217-226.
12. Cortner JA, Coates PM, Gallagher PR. Prevalence and expression of familial combined hyperlipidemia in childhood. J Pediatr 1990;116:514-519.
13. Hamill PVV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM. Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr 1979;32:607-629.
14. Christensen B, Glueck C, Kwiterovich P, Degroot I, Chase G, Heiss G, Mowery R, Tamir I, Rifkind B. Plasma cholesterol and triglyceride distribution in 13 665 children and adolescents: the prevalence study of the Lipid Research Clinics Program. Pediatr Res 1980;14:194-202.
15. The Lipid Research Clinics Population Studies Data Book. Vol. I. The prevalence study. NIH publication 8:1527. Bethesda, MD: National Institutes of Health, 1980.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of plasma low density lipoprotein cholesterol concentration without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
17. SPSS Statistical Data Analysis. Chicago, IL: SPSS, 1992.
18. Polonsky SM, Simbartl LA, Sprecher DL. Triglyceride and high density lipoprotein cholesterol: predicting disorders in parents from their children. Pediatrics 1994;94:824-831.
19. Cortner JA, Coates PM, Bennett MJ, Cryer DR, Le N-A. Familial combined hyperlipidemia: use of stable isotopes to demonstrate overproduction of very low-density lipoprotein apolipoprotein B by the liver. J Inherit Metab Dis 1991;14:915-922.
20. Venkatesan S, Cullen P, Pacy P, Halliday D, Scott J. Stable isotopes show a direct relation between VLDL apo B overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arteriosclerosis Thromb 1993;13:1110-1118.
21. Chait A, Albers JJ, Brunzell JD. Very low density lipoprotein overproduction in genetic forms of hypertriglyceridemia. Eur J Clin Invest 1980;10:17-22.
22. Williams JK, Petrie K, Brocia RW, Swenson TL. Lipoprotein lipase modulates net secretory output of apolipoprotein B in vitro. J Clin Invest 1991;80:1300-1306.
23. Babirak SP, Brown BG, Brunzell JD. Familial combined hyperlipidemia and abnormal lipoprotein lipase. Arteriosclerosis Thromb 1992;12:1176-1183.
24. Cabezas MC, de Bruin TWA, de Valk HW, Shoulders CC, Jansen H, Erkelens DW. Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance. J Clin Invest 1993;92:160-168.
25. Sniderman A, Baldo A, Cianflone K. The potential role of acylation stimulating protein as a determinant of plasma triglyceride clearance and intracellular triglyceride synthesis. Curr Opin Lipidol 1992;3:202-207.
26. Dixon JL, Furukawa S, Ginsberg HN. Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. J Biol Chem 1991;266:5080-5086.
27. Aalto-Setälä K, Fisher EA, Chen X, Chajek-Shaul T, Hayek T, Zechner R, Walsh A, Ramakrishnan R, Ginsberg MN, Breslow JL. Mechanism of hypertriglyceridemia in human apolipoprotein (apo)C-III transgenic mice. J Clin Invest 1992;90:1889-1900.
28. Reaven GM, Mondon CE, Chen YI, Breslow JL. Hypertriglyceridemic mice transgenic for the human apolipoprotein C-III gene are neither insulin resistant nor hyperinsulinemic. J Lipid Res 1994;35:820-824.